Clinical Trial Update: Study to Evaluate the Safety, Tolerate, Pharmacokinetics and Preliminary Efficacy of CYH33 [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated safety, tolerability, pharmacokinetics and preliminary efficacy of CYH33 in patients with solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• CYH33

Snippet

Sponsor: Haihe Biopharma Co., Ltd. | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED